OLYMPUS CORP/S (OTCMKTS:OCPNY) issued its earnings results on Friday. The company reported $0.31 EPS for the quarter, missing the consensus estimate of $0.37 by ($0.06), Morningstar.com reports. The company had revenue of $1.77 billion for the quarter, compared to analysts’ expectations of $1.87 billion. OLYMPUS CORP/S had a return on equity of 4.84% and a net margin of 2.65%.
Shares of OTCMKTS OCPNY traded down $0.02 during trading on Friday, hitting $41.84. 1,876 shares of the company were exchanged, compared to its average volume of 7,797. The firm has a market capitalization of $14.34 billion, a P/E ratio of 27.71, a PEG ratio of 5.81 and a beta of 0.89. OLYMPUS CORP/S has a 1 year low of $26.77 and a 1 year high of $43.24. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.42.
OCPNY has been the topic of several research analyst reports. Goldman Sachs Group upgraded shares of OLYMPUS CORP/S from a “neutral” rating to a “buy” rating in a research report on Thursday, December 20th. ValuEngine lowered shares of OLYMPUS CORP/S from a “buy” rating to a “hold” rating in a research report on Thursday, December 27th. Finally, Zacks Investment Research upgraded shares of OLYMPUS CORP/S from a “sell” rating to a “hold” rating in a research report on Friday, December 28th.
About OLYMPUS CORP/S
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. The company operates through four segments: Medical Business, Scientific Solutions Business, Imaging Business, and Others. It offers endoscopic video endoscopy systems, endoscopic ultrasound systems, ultrasound endoscopes and probes, endoscopic ultrasound observation devices, capsule endoscopy systems, integrated documentation systems, therapeutic equipment, and ancillary products; cleaning, disinfecting, and sterilization systems; gastrointestinal, colono, duodeno, and broncho endoscopes; endoscopy products for gastroenterological surgery, bronchial surgery, urology, gynecology, orthopedic surgery, neurosurgery, and anesthesiology, as well as ear, nose, and throat; and therapeutic and surgical equipment, endoscope ancillary equipment, and endotherapy devices.
Featured Article: How are institutional investors different from individual investors?
Receive News & Ratings for OLYMPUS CORP/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OLYMPUS CORP/S and related companies with MarketBeat.com's FREE daily email newsletter.